Search

The company has been included in the World’s Growth Leaders ranking compiled by TIME magazine and Statista, which highlights the publicly traded companies with the strongest growth and financial

Oryzon Genomics, a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the first patient has been enrolled in IDEAL, its Phase II study evaluating

Spanish biotechnology company BioClonal is advancing a proprietary monoclonal antibody program targeting a novel Alzheimer’s disease-related target and will leverage its participation at BIO